SRSF2 and essential thrombocythemia: Based on these observations, SH2B3, SF3B1, U2AF1, TP53, IDH2, and EZH2 were included as adverse mutations in ET and ASXL1, SRSF2, and IDH2 as adverse mutations in PV.